ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Mylan Pharmaceuticals, Inc. (MYL) Gets FDA Approval for New Product


11/29/2012 8:18:06 AM

Mylan Pharmaceuticals Inc. has received final approval to market tolterodine tablets, the generic version of Pharmacia and Upjohn’s Detrol, which is a treatment for overactive bladder, Canonsburg-based Mylan Inc. (NASDAQ:MYL) announced on Thursday. Tolterodine tablets in the one and two milligram tablet formulations had U.S. sales of approximately $61.5 million for the year ending Sept. 30, according to IMS Health. Mylan is immediately shipping the product.

 
 Read Article at  Related Companies  News Categories
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES